NanoViricides, Inc. (NNVC) stock
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
$1.23−0.12 (-8.89%)
Close on Nov 13, 2026Market cap $31.40MP/E –Yield –
NanoViricides cash
Cash and short-term investments held at the end of each period.
NanoViricides's cash was $2.79M at Jun 30, 2026. For fiscal 2026 it was $2.79M, up 79.3% from the year before. Over ten years it grew -19.4% a year on average. The highest annual figure on record is $36.70M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.79M | +79.3% |
| FY2025 | Jun 30, 2025 | $1.56M | -67.5% |
| FY2024 | Jun 30, 2024 | $4.80M | -41.1% |
| FY2023 | Jun 30, 2023 | $8.15M | -42.1% |
| FY2022 | Jun 30, 2022 | $14.07M | -31.4% |
| FY2021 | Jun 30, 2021 | $20.52M | +49.7% |
| FY2020 | Jun 30, 2020 | $13.71M | +436.5% |
| FY2019 | Jun 30, 2019 | $2.56M | -63.9% |
| FY2018 | Jun 30, 2018 | $7.08M | -53.1% |
| FY2017 | Jun 30, 2017 | $15.10M | -37.5% |
| FY2016 | Jun 30, 2016 | $24.16M | -23.2% |
| FY2015 | Jun 30, 2015 | $31.47M | -14.2% |
| FY2014 | Jun 30, 2014 | $36.70M | +163.6% |
| FY2013 | Jun 30, 2013 | $13.92M | -2.5% |
| FY2012 | Jun 30, 2012 | $14.27M | +54.8% |
| FY2011 | Jun 30, 2011 | $9.22M | +32.6% |
| FY2010 | Jun 30, 2010 | $6.96M | +311.7% |
| FY2009 | Jun 30, 2009 | $1.69M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $2.79M | +79.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $3.21M | +26.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $5.15M | +30.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.13M | -70.9% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.56M | -67.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.54M | -21.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.96M | -24.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $3.87M | -44.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $4.80M | -41.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $3.26M | -66.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $5.25M | -54.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $6.97M | -46.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $8.15M | -42.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $9.65M | -38.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $11.45M | -34.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $12.92M | -34.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $14.07M | -31.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $15.57M | -32.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $17.34M | -5.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $19.70M | -9.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $20.52M | +49.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $22.90M | +275.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $18.39M | +2499.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $21.79M | +2390.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $13.71M | +436.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $6.11M | +44.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $707.65K | -81.9% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $874.95K | -85.6% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $2.56M | -63.9% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $4.24M | -60.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $3.90M | -67.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $6.08M | -55.0% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $7.08M | -53.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $10.62M | -34.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $12.05M | -37.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $13.51M | -38.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $15.10M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $16.16M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $19.30M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $21.91M | – |
See a number that looks wrong?